NCT03097094 is a NA clinical trial of Male dog in Allergy; Dander, sponsored by Copenhagen Studies on Asthma in Childhood.

Who is sponsoring NCT03097094?

NCT03097094 is sponsored by Copenhagen Studies on Asthma in Childhood.

What drugs are being tested in NCT03097094?

Interventions in NCT03097094: Male dog, Female dog.

What condition does NCT03097094 study?

NCT03097094 studies Allergy; Dander.

Is NCT03097094 still recruiting?

NCT03097094 is currently completed. Last updated 15 November 2022.

Last reviewed 2022-11-15 · How we verify

NCT03097094

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Precision Allergy: Separate Allergies to Male and Female Dogs

Completed NA Last updated 15 November 2022

What this trial tests

NA trial testing Male dog in Allergy; Dander in 22 participants. Completed in 9 January 2019.

Timeline

24 March 2017

Primary endpoint
1 September 2017

9 January 2019

Quick facts

Lead sponsor	Copenhagen Studies on Asthma in Childhood
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	quadruple
Primary purpose	diagnostic
Enrollment	22
Start date	24 March 2017
Primary completion	1 September 2017
Estimated completion	9 January 2019
Sites	1 location across Denmark

Drugs / interventions tested

Male dog
Female dog

Conditions studied

Allergy; Dander — all drugs for Allergy; Dander →

Sponsor

Copenhagen Studies on Asthma in Childhood — full company profile →

Who can join

15 and older, any sex, with Allergy; Dander. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A new male-specific dog-allergen-component has been found (Can f 5) which indicates possible differences in allergic reactions to male and female dogs. This has not yet been tested in real life. The aim is to test if sensitization only to the male-dog specific allergen-component, Can f 5, results in a positive skin prick test (SPT) to male dog extract and not female dog extract. In addition, the investigators want to investigate if allergic symptoms only occur when exposed to the male dog extract by conjunctival provocation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Copenhagen Studies on Asthma in Childhood trials

Trials by the same sponsor.

NCT05028153 — Azithromycin Treatment of Hospitalized Children With Asthmatic Symptoms · Phase 2 · recruiting
NCT05043116 — High-dose Vitamin D Supplement for the Prevention of Acute Asthma-like Symptoms in Preschool Children · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03097094 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Copenhagen Studies on Asthma in Childhood
Last refreshed: 15 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03097094.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing